Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
8158 On Other Exchanges
Symbol
Exchange
8158 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

china regenerative medicine (8158) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CHINA REGENERATIVE MEDICINE (8158)

Related News

No related news articles were found.

china regenerative medicine (8158) Related Businessweek News

No Related Businessweek News Found

china regenerative medicine (8158) Details

China Regenerative Medicine International Limited, an investment holding company, is engaged in the research, development, production, and sale of tissue engineering skin related products. The company’s tissue engineering skin products include ActivSkin, which is used to cure injuries due to accidents and diseases occurring from infection, ulcer, burn, complication of surgeries, and congenital abnormalities; and Acellular Cornea for the treatment of various kinds of cornea diseases, including cornea lamellar defect, cornea alkali burn, and bacteria corneal ulcer. Its other development products comprise Selective Acellular Porcine Skin for the treatment of various skin injuries, infected, and deficient wounds, as well as enhance healing of scars and chronic non-healing ulcers and prevent recurrence; and Boactive cosmetics. The company was formerly known as China Bio-Med Regeneration Technology Limited and changed its name to China Regenerative Medicine International Limited in March 2015. China Regenerative Medicine International Limited was founded in 1995 and is based in Wanchai, Hong Kong.

352 Employees
Last Reported Date: 07/30/14
Founded in 1995

china regenerative medicine (8158) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: $1.2M
Executive Director
Total Annual Compensation: $1.4M
Compliance Officer and Executive Director
Total Annual Compensation: $1.4M
Compensation as of Fiscal Year 2014.

china regenerative medicine (8158) Key Developments

China Regenerative Medicine International Limited, Board Meeting, Apr 14, 2015

China Regenerative Medicine International Limited, Board Meeting, Apr 14, 2015. Agenda: To pass resolution that Mr. Ma be removed from his position as a non-executive Director of the company with effect from 14 April 2015.

China Regenerative Medicine International Limited Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended January 31, 2015

China Regenerative Medicine International Limited announced unaudited consolidated earnings results for the third quarter and nine months ended January 31, 2015. For the quarter, the company reported revenue of HKD 520,000 against HKD 140,000 a year ago. Loss before income tax was HKD 44,094,000 against HKD 38,216,000 a year ago. Loss for the period attributable to owners of the company was HKD 41,795,000 or 0.351 cents per basic share against HKD 34,739,000 or 0.352 cents per basic share a year ago. For the nine months, the company reported revenue of HKD 2,041,000 against HKD 336,000 a year ago. Loss before income tax was HKD 126,182,000 against HKD 90,678,000 a year ago. Loss for the period attributable to owners of the company was HKD 117,003,000 or 0.988 cents per basic share against HKD 81,469,000 or 0.877 cents per basic share a year ago. The revenue has increased by approximately HKD 1,705,000 as a result of new operation arm Shaanxi Reshine Biotech Co. Ltd. commenced its sales and marketing activities in June 2014.

China Bio-Med Regeneration Technology Limited will Change its Name to China Regenerative Medicine International Limited

Effective March 09, 2015, China Bio-Med Regeneration Technology Limited will change its name to China Regenerative Medicine International Limited.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8158:HK $0.74 HKD +0.01

8158 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 8158.
View Industry Companies
 

Industry Analysis

8158

Industry Average

Valuation 8158 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3,980.1x
Price/Book 11.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 5,409.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHINA REGENERATIVE MEDICINE, please visit www.crmi.hk. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.